DFTX R&D Expense Growth
Definium Therapeutics Inc · R&D Expense Growth
DFTX R&D Expense Growth
Latest reported80.20%period ending
DFTX FY R&D Growth (YoY) (0.00% → 80.20%)
Latest values, visible window
High-resolution chart · PNG
DFTX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 80.1997% | |
| 33.3626% | |
| 35.3701% | |
| 3.9668% | |
| 86.7264% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |